Zimmer Biomet CEO Says Says Excluding Impact Of China Distributor Network Consolidation, Q3 Constant-Currency Sales Growth Would Have Been 4.4%; Global Knees Sales Would Have Been Flat YoY In Q3 Excluding China Headwinds; Expects To File Monogram 510(K) Application With FDA Very Soon, Ahead Of Schedule; China-Related Headwinds Will Anniversary In January 2027, Improving Visibility Into Knees Performance

Benzinga · 1d ago

-Conference Call.